PenderFund Capital Management »

Revance Therapeutics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Revance Therapeutics shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 2.0M 1.00

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Novavax Note 5.000%12/1 Added (Principal)
Burford Cap Ord Shs (BUR)
PAR Technology Corporation (PAR)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Cable One Note 1.125% 3/1 (Principal)
Docebo (DCBO)
Aviat Networks Com New (AVNW)
Nuveen Insured Tax-Free Adv Munici (NEA)

View all positions for PenderFund Capital Management

Top funds holding Revance Therapeutics

Graham Capital Management
Glazer Capital
Nuveen Asset Management
D. E. Shaw & Co
CNH Partners
Morgan Stanley
Jpmorgan Chase & Co
Citigroup
Amundi
Sonora Investment Management Group
BlackRock
BlackRock
Aviva
Brevan Howard Capital Management
CSS

View all funds holding Revance Therapeutics